Wenduine Pharma SRL
3.0 FTEWenduine Pharma reported total assets of €1.25m at the end of the 2025 financial year (annual accounts filed with the NBB on 12 May 2026), with 3 full-time equivalents.
The score of Wenduine Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -26 % Total assets -26 % Headcount (avg FTE) +43 %
Accounts of the company itself (not consolidated).
The full file covers 17 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wenduine Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 May 2026
- Year ended 31 Dec 2024filed on 16 Jun 2025
- Year ended 31 Dec 2023filed on 11 Jun 2024
- Year ended 31 Dec 2022filed on 09 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Wenduine Pharma's financial analysis
- Solvency86.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wenduine Pharma
Wenduine Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0425.384.986
- VAT number
- BE0425384986
- Peppol
- Registered · 0208:0425384986 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 1983
- Registered office
- 8420 De Haan
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 12 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Wenduine Pharma (SRL) has been based in De Haan since 1983, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 74,220 € and equity of €1.08m; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 86.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Wenduine Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie du Sacre - Coeur Retail sale of pharmaceutical products Tournai · balance sheet €1.00m
- De MOL - Regnier Pharma Retail sale of pharmaceutical products Courcelles · balance sheet 642,568 €
- Axcofarma Retail sale of pharmaceutical products Diepenbeek · balance sheet 489,172 €
- Pharbel Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet €2.83m
- Apotheek BAKELANTS Retail sale of pharmaceutical products Geel · balance sheet €1.18m
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Farmafrance Retail sale of pharmaceutical products Halle · balance sheet €1.38m
- Alphar Immo Retail sale of pharmaceutical products Libramont-Chevigny · balance sheet €2.23m
Frequently asked questions about Wenduine Pharma
What is the revenue of Wenduine Pharma?
Wenduine Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wenduine Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0425384986 for Wenduine Pharma, if the company is VAT-registered. Its company number (CBE) is 0425.384.986.
Where is the registered office of Wenduine Pharma?
According to the CBE register, the registered office of Wenduine Pharma is in 8420 De Haan.
What is the equity of Wenduine Pharma?
At the close of the 2025 financial year, the equity of Wenduine Pharma amounts to 1,082,155 €, a solvency of 86.7% of total assets.
How many people work at Wenduine Pharma?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Wenduine Pharma?
The register lists 5 active mandates at Wenduine Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wenduine Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →